BFRI Biofrontera Inc.
Healthcare$0.80-1.52%ClosedMarket Cap: $10.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.55
P/S
0.24
EV/EBITDA
-1.42
DCF Value
$-29.82
FCF Yield
-90.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.8%
Operating Margin
-20.6%
Net Margin
-25.7%
ROE
-476.7%
ROA
-44.7%
ROIC
-62.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $10.1M | 81.8% | $-4.3M | $-4.8M | $— | — |
| Q4 null | $17.1M | 94.9% | $6.8M | $5.6M | $— | — |
| FY null | $41.7M | 78.7% | $-9.1M | $-10.5M | $— | — |
| Q3 null | $7.0M | 70.4% | $-6.3M | $-6.6M | $— | — |
| Q2 null | $9.0M | 70.5% | $-5.1M | $-5.3M | $— | — |
| Q1 null | $8.6M | 61.6% | $-4.5M | $-4.2M | $— | — |
| Q4 null | $12.6M | 58.0% | $-1.7M | $-1.4M | $— | — |
| FY null | $37.3M | 50.1% | $-17.2M | $-17.8M | $— | — |
| Q3 null | $9.0M | 45.9% | $-5.0M | $-5.7M | $— | — |
| Q2 null | $7.8M | 44.6% | $-5.1M | $-257.0K | $— | — |
| Q1 null | $7.9M | 50.1% | $-5.5M | $-10.4M | $— | — |
| Q4 2023 | $10.6M | 49.3% | $-3.9M | $3.5M | $1.65 | — |